These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 7848515)
41. [An overview of antibody-based cancer therapy]. Miao QF; Shao RG; Zhen YS Yao Xue Xue Bao; 2012 Oct; 47(10):1261-8. PubMed ID: 23289136 [TBL] [Abstract][Full Text] [Related]
42. Affinity of recombinant antibody and antibody fragment binding to human thyroglobulin: potential applications in gene therapy. Mani JC; Noel D; Marin M; Navarro-Teulon I; Biard-Piechaczyk M; Pau B; Piechaczyk M J Mol Recognit; 1998; 11(1-6):117-8. PubMed ID: 10076821 [TBL] [Abstract][Full Text] [Related]
43. A new generation of monoclonal and recombinant antibodies against cell-adherent prostate specific membrane antigen for diagnostic and therapeutic targeting of prostate cancer. Elsässer-Beile U; Wolf P; Gierschner D; Bühler P; Schultze-Seemann W; Wetterauer U Prostate; 2006 Sep; 66(13):1359-70. PubMed ID: 16894535 [TBL] [Abstract][Full Text] [Related]
45. Biting the magic bullet. Radiolabelled monoclonal antibodies: the next great step forward in the diagnosis and treatment of cancer? Persaud RD Med Hypotheses; 1988 Nov; 27(3):245-51. PubMed ID: 3062339 [TBL] [Abstract][Full Text] [Related]
46. [Monoclonal antibodies and their potential application to medicine]. Weber S Z Erkr Atmungsorgane; 1985; 165(1):3-12. PubMed ID: 2414929 [TBL] [Abstract][Full Text] [Related]
47. Immunological approaches to tumor therapy. Monoclonal antibodies, tumor vaccines, and anti-idiotypes. Hellström KE; Hellström I Targeted Diagn Ther; 1989; 2():1-39. PubMed ID: 2519542 [No Abstract] [Full Text] [Related]
48. [Current status and perspectives of immunodiagnosis and immunotherapy in oncology]. Pfreundschuh M Med Klin (Munich); 1987 Apr; 82(9):320-9. PubMed ID: 3600548 [No Abstract] [Full Text] [Related]
50. [Monoclonal antibodies in the treatment of hematological malignancies]. Itälä M Duodecim; 2002; 118(16):1647-56. PubMed ID: 12271942 [No Abstract] [Full Text] [Related]
51. Review: advances in monoclonal antibody tumour targeting. Kosmas C; Linardou H; Epenetos AA J Drug Target; 1993; 1(2):81-91. PubMed ID: 8069556 [TBL] [Abstract][Full Text] [Related]
52. [Lymphocyte hybridization and cancerology: diagnostic and therapeutic applications. Example of tumor markers]. Cazin JL; Gosselin P; Demaille A Pathol Biol (Paris); 1993 Nov; 41(9):881-6. PubMed ID: 8121720 [TBL] [Abstract][Full Text] [Related]
53. Overview of monoclonal antibodies in cancer therapy: present and promise. Stern M; Herrmann R Crit Rev Oncol Hematol; 2005 Apr; 54(1):11-29. PubMed ID: 15780905 [TBL] [Abstract][Full Text] [Related]
55. Target therapy of cancer: implementation of monoclonal antibodies and nanobodies. Majidi J; Barar J; Baradaran B; Abdolalizadeh J; Omidi Y Hum Antibodies; 2009; 18(3):81-100. PubMed ID: 19729803 [TBL] [Abstract][Full Text] [Related]
56. [Carcinogenesis and immunobiology of tumors. Scientific and clinical aspects]. Granov AM; Molchanov OE Vopr Onkol; 2008; 54(4):401-9. PubMed ID: 18942393 [No Abstract] [Full Text] [Related]
57. Antibodies in oncology. Pillay V; Gan HK; Scott AM N Biotechnol; 2011 Sep; 28(5):518-29. PubMed ID: 21473941 [TBL] [Abstract][Full Text] [Related]
58. [Monoclonal antibodies for diagnosis and therapy in oncological patients]. Boven E; Haisma HJ; Pinedo HM Ned Tijdschr Geneeskd; 1995 Dec; 139(49):2552-8. PubMed ID: 8657317 [No Abstract] [Full Text] [Related]
59. From monoclonal antibodies to chimeric antigen receptors for the treatment of human malignancies. Caruana I; Diaconu I; Dotti G Semin Oncol; 2014 Oct; 41(5):661-6. PubMed ID: 25440610 [TBL] [Abstract][Full Text] [Related]
60. Figures of merit (FOMs) for imaging and therapy using monoclonal antibodies. Williams LE; Liu A; Wu AM; Odom-Maryon T; Chai A; Raubitschek AA; Wong JY Med Phys; 1995 Dec; 22(12):2025-7. PubMed ID: 8746707 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]